An Interview with Chifundo Stubbs

Chifundo Stubbs is a Clinical Research Nurse at NIHR Wellcome King’s Clinical Research Facility (CRF), a purpose-built facility to support clinical trials in mental health, neurology, general and acute medicine.

By NIHR Maudsley BRC at 12 May 2021

An interview with Dr Faith Matcham

Dr Faith Matcham is the NIHR Maudsley BRC Research Champion for diversity and inclusion. Faith also co-ordinates the major depression study within RADAR-CNS, which uses data collected from wearable devices and smartphone sensors to predict health outcomes in people with major depressive disorder, epilepsy and MS.

 

By NIHR Maudsley BRC at 19 Apr 2021

Latest COVID-19 Vaccine Study in the UK Launches in London

On Wednesday 14th April, the latest COVID-19 vaccine study was launched in London, with the King's Clinical Research Facility being one of the sites taking part. Sponsored by Canadian biopharmaceutical company Medicago and GlaxoSmithKline, the Phase 3 clinical trial will test the safety and efficacy of a plant-derived vaccine candidate named CoVLP.

By NIHR King's Clinical Research Facility at 14 Apr 2021

Cognitive flexibility potential new target in treatment resistant schizophrenia

Researchers at King’s College London have found that an important brain mechanism that allows us to switch between thinking about two or more ideas may help treat patients with schizophrenia who do not respond well to current treatments. 

By NIHR Maudsley BRC at 1 Apr 2021

IBS Digital therapeutic Parallel™ developed by King’s researchers gets approval in UK and US

Parallel™ is the first prescription only digital therapeutic to provide cognitive behavioural therapy (CBT)  to adults with irritable bowel syndrome (IBS) to receive the FDA Marketing Authorization in the US.  ParallelTM has also obtained a CE mark and been recommended for Evaluation in Practice by the National Institute for Health and Care Excellence (NICE).

 

By NIHR Maudsley BRC at 1 Apr 2021